Dr Abha Gour from Dr Shroff’s Charity Eye Hospital visited ELZA to discuss visual rehabilitation in keratoconus, including ELZA-PACE and corneal wavefront-guided TransPRK.
Who is the best eye doctor in Zurich? In Switzerland? Or even globally? Such questions are inherently subjective. However, structured peer recognition within the international ophthalmic community provides a meaningful benchmark for clinical impact, innovation, and leadership.
Every two years, The Ophthalmologist publishes its Power List, which features either 50 or 100 individuals, depending on the year, who are regarded as pioneers in the future of ophthalmology thanks to their research, surgical innovations and global influence.
Who is the best eye doctor in Zurich? In Switzerland? In the world? While such questions are inherently subjective, peer recognition provides a meaningful benchmark.
Medical trade journal, The Ophthalmologist seeks to answer this by publishing its biennial Power List—a global selection of the 100 most influential individuals shaping the future of ophthalmology.
Nikki Hafezi-Kristoffersen, MAS IP ETHZ, CEO of the ELZA Institute and executive at the MESCA Foundation, recently visited the Bukhara State Medical Institute (BSMI).
Visit ELZA Zurich HB, our modern eye clinic in Zurich Hauptbahnhof. Find us at Bahnhofplatz 15, 2nd floor, Ostrisalit – above The Counter.
Our Institute is closed 24 Dec 2023 to 2 Jan 2024 for the holidays.
Happy Holidays and a Prosperous New Year to all!
Sunday, September 10th, 2023, continued the trend of informative presentations at the ESCRS 2023 conference in Vienna. Here’s a straightforward rundown of the day’s events:
Saturday, September 9th, 2023, presented another day of informative sessions at the ESCRS 2023 conference in Vienna. Here’s a straightforward overview of the day’s events.
The European Society of Cataract and Refractive Surgeons (ESCRS) 2023 conference unfolded at Vienna’s Messe Wien, Austria. Today, September 8th, 2023, was marked by a
Shaopei Wang et al. wanted to know who are the current “big hitters” in corneal cross-linking (CXL) research, so they performed and published a literature
